A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
Authors
Keywords
acute kidney injury, dapagliflozin, chronic kidney disease, SGLT2 inhibitors
Journal
KIDNEY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-22
DOI
10.1016/j.kint.2021.09.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in Cardiovascular Biomarkers Associated With the Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Ertugliflozin in Patients With Chronic Kidney Disease and Type 2 Diabetes
- (2021) Patrick R. Lawler et al. DIABETES CARE
- Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial
- (2021) Michael E. Nassif et al. CIRCULATION
- Generalizability of DAPA-CKD to the United States
- (2021) Rahul Aggarwal et al. Circulation-Cardiovascular Quality and Outcomes
- Acute Kidney Injury Events in Patients With Type 2 Diabetes Using SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs: A Retrospective Cohort Study
- (2020) Christie Rampersad et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Use of sodium–glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study
- (2020) Carina Iskander et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- We Can Finally Stop Worrying About SGLT2 Inhibitors and Acute Kidney Injury
- (2020) Vikas S. Sridhar et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
- (2020) David Z I Cherney et al. Lancet Diabetes & Endocrinology
- Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF
- (2020) Pardeep S. Jhund et al. CIRCULATION
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury
- (2020) Min Zhao et al. Clinical Journal of the American Society of Nephrology
- SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
- (2019) Brendon L Neuen et al. Lancet Diabetes & Endocrinology
- Rethinking progression of CKD as a process of punctuated equilibrium
- (2018) Richard J. Johnson et al. Nature Reviews Nephrology
- Acute renal outcomes with SGLT-2 inhibitors - real world data analysis
- (2018) Avivit Cahn et al. DIABETES OBESITY & METABOLISM
- A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor–dependent pathway after renal injury in mice
- (2018) Yifan Zhang et al. KIDNEY INTERNATIONAL
- Sodium glucose cotransporter 2 inhibition and renal ischemia: implications for future clinical trials
- (2018) Daniël H. van Raalte et al. KIDNEY INTERNATIONAL
- Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: Analysis of the FDA adverse event report system database
- (2017) A. Perlman et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial
- (2016) David Fitchett et al. EUROPEAN HEART JOURNAL
- A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury
- (2015) Matthew T. James et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- SAS Macro for Causal Mediation Analysis with Survival Data
- (2015) Linda Valeri et al. EPIDEMIOLOGY
- Do Tubular Changes in the Diabetic Kidney Affect the Susceptibility to Acute Kidney Injury?
- (2014) Volker Vallon NEPHRON CLINICAL PRACTICE
- World Incidence of AKI: A Meta-Analysis
- (2013) P. Susantitaphong et al. Clinical Journal of the American Society of Nephrology
- Acute Kidney Injury Episodes and Chronic Kidney Disease Risk in Diabetes Mellitus
- (2011) C. V. Thakar et al. Clinical Journal of the American Society of Nephrology
- Causal Mediation Analysis With Survival Data
- (2011) Tyler J. VanderWeele EPIDEMIOLOGY
- Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis
- (2011) Steven G. Coca et al. KIDNEY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started